Form 4: EBR Systems CFO Gary W. Doherty Granted 500,000 Stock Options
Insider Transaction Report
EBR Systems, Inc. Chief Financial Officer Gary W. Doherty was granted 500,000 stock options with an exercise price of $0.75, vesting monthly over four years.
Summary
- Gary W. Doherty, the Chief Financial Officer of EBR Systems, Inc., was granted 500,000 stock options.
- The stock options have an exercise price of $0.75 per share.
- The options will vest in equal monthly installments of 1/48th, commencing from June 25, 2025.
- Vesting is contingent upon Mr. Doherty's continued employment or service with the company.
- The options are set to expire on June 24, 2035.
- This transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.
Sentiment
Score: 7
Explanation: The grant of stock options to a key executive like the CFO is generally viewed positively as it aligns management's long-term interests with shareholder value creation and aids in executive retention, representing a standard and beneficial compensation practice.
Positives
- The grant of stock options to the Chief Financial Officer aligns management's long-term financial interests with those of the shareholders.
- The multi-year vesting schedule (48 months) serves as an incentive for executive retention and continued commitment to the company's performance.
Negatives
- The exercise of these options in the future could lead to dilution for existing shareholders.
Risks
- The vesting of the options is subject to continued employment, meaning unvested options would be forfeited if the CFO's employment ceases.
- Potential future dilution of existing shareholder equity if and when the 500,000 stock options are exercised.
Future Outlook
The options will vest monthly over 48 months, contingent on the CFO's continued employment, aligning executive incentives with long-term company performance.
Industry Context
This stock option grant is a common practice in the technology and medical device industries to incentivize and retain key executives, aligning their financial interests with the long-term performance of the company.
Comparison to Industry Standards
- The grant of 500,000 stock options to a Chief Financial Officer is a significant equity award, typical for a growth-oriented company like EBR Systems, Inc. in the medical device sector.
- While specific comparable companies are not named in the filing, such grants are standard practice for retaining and motivating senior leadership, often structured with multi-year vesting schedules similar to those seen at peers in the med-tech space, ensuring long-term commitment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adherence | The stock option grant was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan designed to comply with insider trading laws and provide an affirmative defense against insider trading allegations. | 06/25/2025 | Enhances transparency and reduces potential for insider trading concerns related to executive equity transactions. |
Stakeholder Impact
- Shareholders: Potential future dilution if options are exercised, but also benefit from aligned management incentives and executive retention.
- Management: The Chief Financial Officer receives a significant equity incentive, aligning personal financial success with company performance.
Next Steps
- Continued monthly vesting of the stock options over the next 48 months, subject to the CFO's continued employment.
Key Dates
| Date | Description |
|---|---|
| 06/25/2025 | Date of earliest transaction (stock option grant date) and commencement of the vesting period. |
| 06/27/2025 | Date the Form 4 filing was signed. |
| 06/24/2035 | Expiration date of the granted stock options. |
Recommendation
holdKeywords
EBR Systems, Stock Options, Gary W. Doherty, CFO, Executive Compensation, SEC Form 4, Equity Grant, Rule 10b5-1, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.